China National Medicines Corp Ltd (600511) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China National Medicines Corp Ltd (600511) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-540.00 Million ≈ $-79.02 Million USD) by net assets (CN¥19.93 Billion ≈ $2.92 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See China National Medicines Corp Ltd balance sheet quality to measure how much of total assets are equity-financed.
China National Medicines Corp Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how China National Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of China National Medicines Corp Ltd to evaluate the quality of earnings relative to operating cash generation.
China National Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China National Medicines Corp Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shufersal
TA:SAE
|
0.144x |
|
COFCO Capital Holdings Co Ltd
SHE:002423
|
0.249x |
|
Nicolet Bankshares Inc.
NYSE:NIC
|
0.007x |
|
WIENERBERGER ADR 1/5/O.N.
F:WIBA
|
N/A |
|
LG Display
KO:034220
|
0.078x |
|
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
|
0.065x |
|
Hayward Holdings Inc
NYSE:HAYW
|
-0.093x |
|
Rev Group Inc
NYSE:REVG
|
0.185x |
Annual Cash Flow Conversion Efficiency for China National Medicines Corp Ltd (2001–2024)
The table below shows the annual cash flow conversion efficiency of China National Medicines Corp Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see 600511 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥18.98 Billion ≈ $2.78 Billion |
CN¥1.66 Billion ≈ $242.78 Million |
0.087x | -43.78% |
| 2023-12-31 | CN¥17.53 Billion ≈ $2.57 Billion |
CN¥2.73 Billion ≈ $399.00 Million |
0.156x | +2.97% |
| 2022-12-31 | CN¥15.86 Billion ≈ $2.32 Billion |
CN¥2.40 Billion ≈ $350.48 Million |
0.151x | +10.76% |
| 2021-12-31 | CN¥14.36 Billion ≈ $2.10 Billion |
CN¥1.96 Billion ≈ $286.44 Million |
0.136x | +37.17% |
| 2020-12-31 | CN¥13.09 Billion ≈ $1.92 Billion |
CN¥1.30 Billion ≈ $190.48 Million |
0.099x | -31.95% |
| 2019-12-31 | CN¥12.16 Billion ≈ $1.78 Billion |
CN¥1.78 Billion ≈ $259.89 Million |
0.146x | +57.88% |
| 2018-12-31 | CN¥10.61 Billion ≈ $1.55 Billion |
CN¥981.65 Million ≈ $143.65 Million |
0.093x | -18.57% |
| 2017-12-31 | CN¥9.46 Billion ≈ $1.38 Billion |
CN¥1.07 Billion ≈ $157.23 Million |
0.114x | -22.81% |
| 2016-12-31 | CN¥4.02 Billion ≈ $587.79 Million |
CN¥591.25 Million ≈ $86.52 Million |
0.147x | +17.49% |
| 2015-12-31 | CN¥3.51 Billion ≈ $514.25 Million |
CN¥440.29 Million ≈ $64.43 Million |
0.125x | +47.68% |
| 2014-12-31 | CN¥2.58 Billion ≈ $377.65 Million |
CN¥218.94 Million ≈ $32.04 Million |
0.085x | +0.39% |
| 2013-12-31 | CN¥2.20 Billion ≈ $321.31 Million |
CN¥185.56 Million ≈ $27.15 Million |
0.085x | -15.00% |
| 2012-12-31 | CN¥1.87 Billion ≈ $273.56 Million |
CN¥185.87 Million ≈ $27.20 Million |
0.099x | +141.13% |
| 2011-12-31 | CN¥1.53 Billion ≈ $224.31 Million |
CN¥-370.56 Million ≈ $-54.22 Million |
-0.242x | -202.04% |
| 2010-12-31 | CN¥1.34 Billion ≈ $196.55 Million |
CN¥318.21 Million ≈ $46.56 Million |
0.237x | +0.56% |
| 2009-12-31 | CN¥1.08 Billion ≈ $158.49 Million |
CN¥255.18 Million ≈ $37.34 Million |
0.236x | -5.77% |
| 2008-12-31 | CN¥868.25 Million ≈ $127.05 Million |
CN¥217.10 Million ≈ $31.77 Million |
0.250x | +128.39% |
| 2007-12-31 | CN¥725.96 Million ≈ $106.23 Million |
CN¥79.48 Million ≈ $11.63 Million |
0.109x | -46.75% |
| 2006-12-31 | CN¥590.99 Million ≈ $86.48 Million |
CN¥121.50 Million ≈ $17.78 Million |
0.206x | +16.24% |
| 2005-12-31 | CN¥521.33 Million ≈ $76.29 Million |
CN¥92.20 Million ≈ $13.49 Million |
0.177x | +75.64% |
| 2004-12-31 | CN¥488.38 Million ≈ $71.47 Million |
CN¥49.18 Million ≈ $7.20 Million |
0.101x | +8868.91% |
| 2003-12-31 | CN¥468.65 Million ≈ $68.58 Million |
CN¥526.15K ≈ $76.99K |
0.001x | -97.05% |
| 2002-12-31 | CN¥399.62 Million ≈ $58.48 Million |
CN¥15.19 Million ≈ $2.22 Million |
0.038x | +143.44% |
| 2001-12-31 | CN¥134.77 Million ≈ $19.72 Million |
CN¥-11.80 Million ≈ $-1.73 Million |
-0.088x | -- |
About China National Medicines Corp Ltd
China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental academic services, warehousing, logistics and import and export agency services. It also serves hospitals, re… Read more